Is DVAX or RYLD a better dividend investment in 2026?

DVAX currently yields 12.90% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: DVAX offers higher current income.

What is the dividend yield difference between DVAX and RYLD?

DVAX has a forward dividend yield of 12.90% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 0.76 percentage points.

Home › Compare › DVAX vs RYLD

DVAX vs RYLD: Dividend Comparison 2026

DVAX yields 12.90% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DVAX wins by $2.3K in total portfolio value

INVESTMENT

TIME HORIZON10 years

DVAX

● Live price

12.90%

Share price

$15.50

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$46.8K

Annual income

$2,879.44

Full DVAX calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — DVAX vs RYLD

📍 DVAX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DVAX	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DVAX + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

DVAX pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DVAX

Annual income on $10K today (after 15% tax)

$1,096.77/yr

After 10yr DRIP, annual income (after tax)

$2,447.52/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, DVAX beats the other by $248.28/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DVAX + RYLD for your $10,000?

DVAX: 50%RYLD: 50%

100% RYLD50/50100% DVAX

Portfolio after 10yr

$45.7K

Annual income

$2,733.39/yr

Blended yield

5.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on DVAX right now

DVAX

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$27.00

+74.2% upside vs current

Range: $20.00 — $32.00

Altman Z

2.4

Piotroski

6/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DVAX buys

RYLD buys

No recent congressional trades found for DVAX or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDVAXRYLD

Forward yield	12.90% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$46.8K ✓	$44.5K
Annual income after 10y	$2,879.44 ✓	$2,587.35
Total dividends collected	$20.6K ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: DVAX vs RYLD ($10,000, DRIP)

Year	DVAX Portfolio	DVAX Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$11,990	$1,290.32	$11,914	$1,213.65	+$76.00 → DVAX
2	$14,276	$1,445.92	$14,099	$1,351.30	+$177.00 → DVAX
3	$16,884	$1,608.88	$16,580	$1,494.55	+$304.00 → DVAX
4	$19,844	$1,778.34	$19,384	$1,642.61	+$460.00 → DVAX
5	$23,186	$1,953.40	$22,535	$1,794.70	+$651.00 → DVAX
6	$26,943	$2,133.11	$26,063	$1,950.00	+$880.00 → DVAX
7	$31,145	$2,316.51	$29,995	$2,107.69	+$1.1K → DVAX
8	$35,828	$2,502.66	$34,361	$2,266.99	+$1.5K → DVAX
9	$41,026	$2,690.60	$39,194	$2,427.12	+$1.8K → DVAX
10	$46,778	$2,879.44	$44,525	$2,587.35	+$2.3K → DVAX

DVAX vs RYLD: Complete Analysis 2026

DVAX — Stock

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

Full DVAX Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this DVAX vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DVAX vs SCHD DVAX vs JEPI DVAX vs O DVAX vs KO DVAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.